呼吸系统微生物群与喘之间的联系:一种新兴的治疗方法
Chunyuan Tian1,2, Xing Li2, Xingxing Yuan1,3
1Department of Graduate School, Heilongjiang University of Chinese Medicine Harbin 150040, Heilongjiang, China.
American journal of translational research
|December 16, 2024
概括
呼吸道微生物群影响喘的发展和进展. 新兴疗法侧重于免疫平衡和喘治疗的肠肺轴.
科学领域:
- 微生物学 微生物学
- 免疫学 免疫学 免疫学
- 肺部病理学 肺部病理学
背景情况:
- 呼吸道微生物群在喘病原发生过程中起着至关重要的作用.
- 在喘患者和健康个体之间存在明显的微生物差异.
- 了解这些差异对于开发新的喘疗法至关重要.
研究的目的:
- 审查呼吸道微生物群与喘之间的关系.
- 确定潜在的治疗点和喘新兴治疗方法.
- 探索肠肺轴在呼吸系统健康中的作用.
主要方法:
- 关于呼吸道微生物群和喘的现有研究的全面综合.
- 检查针对关键免疫路径 (细胞因子,细胞因子) 的免疫调节剂.
- 探索免疫细胞调节和肠肺轴.
主要成果:
- 呼吸道微生物群与喘发病率和进展有很大关系.
- 在呼吸道微生物群中调节免疫平衡显示出治疗前景.
- 肠道微生物群通过肠肺轴影响全身免疫和呼吸系统健康.
结论:
- 针对呼吸道微生物群和免疫路径,为喘提供了新的治疗策略.
- 肠肺轴是喘病理生理学的关键因素.
- 需要进一步的研究才能充分阐明微生物群和喘之间的复杂相互作用.
相关概念视频
Asthma-I: Introduction
2.6K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.6K
Drugs Used in Lower Respiratory Disorders: Overview
349
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
349
Asthma: Pathogenesis and Management
348
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
348
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
236
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
236
Asthma-II: Pathophysiology and Classification
2.6K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.6K
Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K


